Source/Disclosures
Published by:
Disclosures:
Backus reports being chief scientific officer of Vivid Vision.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
BOSTON – Vivid Vision software is indicated for treating convergence insufficiency, stereo depth perception, amblyopia and strabismus either in the clinic or at home, according to a presentation here at the American Academy of Optometry meeting.
Chief science officer Benjamin Backus, PhD, said at an academy-sponsored press conference that the system uses a virtual reality (VR) headset that allows separate images to be presented to the patient’s left and right eyes.
This FDA-approved technology, which uses VR games, is designed for all ages, according to the Vivid Vision website. It supports Vive, Rift and DPVR P1 Pro platforms.
“It is affordable and engaging for patients, especially those who have stopped improving with conventional treatment like patching,” Backus said.
The home version needs to be prescribed by a doctor, he noted.
Backus also said the company is developing Vivid Vision Smart Assist.
“Doctors make two kinds of adjustments during treatment – expert and simple,” he said. “Simple adjustments take time away from treatment. The solution is to make simple adjustments automatically.”
In addition, the company is developing Vivid Vision Perimetry, Backus said.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].